GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...